An improved class of fluorescent silica nanoparticles for indirect immunofluorescence detection of MCF-7 cells
Source abstract
Abstract
Abstract In this work, we have developed an efficient method based on silica fluorescent dye-doped nanoparticles and second antibody for cancer cell labeling. The dye-doped silica nanoparticles were synthesized by the reverse microemulsion method with the conjugate of 3-aminopropyltriethoxysilane and rhodamine B isothiocynate. A PEG with flexible long chain as the bridge was introduced onto the surface of the nanoparticle via cyanogens bromide method. The second antibody, goat anti-rabbit IgG, was conjugated on the surface of the PEG-terminal modified silica fluorescent nanoparticles by covalent binding to the PEG linkers via the EDC/sulfo-NHS method. The concentrations of goat anti-rabbit IgG covering the nanoparticles were quantified via the Bradford method. The silica fluorescent nanoparticles functionalized with rabbit anti-MUC1 antibody were employed as bioprobes for the recognition of MUC1 protein in human breast carcinoma molecules MCF-7 cells. Compared with fluorescent dye labeled IgG, the fluorescent nanoprobes display dramatically increased photostability.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Advanced Biosensing Techniques and Applications · Biosensors and Analytical Detection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. Quantum dot bioconjugates for ultrasensitive nonisotopic detection10.1126/science.281.5385.2016 ↗
2. Semiconductor nanocrystals as fluorescent biological labels10.1126/science.281.5385.2013 ↗
3. Designing multifunctional quantum dots for bioimaging, detection, and drug delivery10.1039/b915139g ↗
4. Tracking single viruses infecting their host cells using quantum dots10.1039/C5CS00657K ↗
5. Potentials and pitfalls of fluorescent quantum dots for biological imaging10.1016/j.tcb.2004.07.012 ↗
6. Bionanotechnology based on silica nanoparticles10.1002/med.20003 ↗
7. Functionalized silica nanoparticles: a platform for fluorescence imaging at the cell and small animal levels10.1021/ar3001525 ↗
8. Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges10.1016/j.molmed.2010.08.006 ↗
9. Glow in the biological world10.1021/ac0693619 ↗
10. Nanoparticles for bioimaging10.1016/j.cis.2006.05.026 ↗
11. Surfactant-mediated fabrication of optical nanoprobes10.1007/12_2008_166 ↗
12. A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles10.1073/pnas.0404806101 ↗
13. Methylene blue-encapsulated phosphonate-terminated silica nanoparticles for simultaneous in vivo imaging and photodynamic therapy10.1016/j.biomaterials.2009.06.030 ↗
14. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles10.1021/ac801882g ↗
15. Nanoparticle-based biocompatible and long-life marker for lysosome labeling and tracking10.1021/ac902417s ↗
16. Multicolor FRET silica nanoparticles by single wavelength excitation10.1021/nl052105b ↗
17. Dual-luminophore-doped silica nanoparticles for multiplexed signaling10.1021/nl048417g ↗
18. Biochemically functionalized silica nanoparticles10.1039/b101489g ↗
19. MUC-1 aptamer-conjugated dye-doped silica nanoparticles for MCF-7 cells detection10.1016/j.biomaterials.2012.09.084 ↗
20. Goat anti-rabbit IgG conjugated fluorescent dye-doped silica nanoparticles for human breast carcinoma cell recognition10.1039/c3an01654d ↗
21. Using fluorescent nanoparticles and SYBR Green I based two-color flow cytometry to determine Mycobacterium tuberculosis avoiding false positives10.1016/j.bios.2008.06.023 ↗
22. Fluorescent nanoparticle-based indirect immunofluorescence microscopy for detection of Mycobacterium tuberculosis10.1155/2007/89364 ↗
23. Covalent conjugation of avidin with dye-doped silica nanoparticles and preparation of high density avidin nanoparticles as photostable bioprobes10.1016/j.bios.2012.04.041 ↗
24. Indirect immunofluorescence detection of E. coli O157:H7 with fluorescent silica nanoparticles10.1016/j.bios.2014.11.007 ↗
25. Epithelial mucin genes10.1146/annurev.ph.57.030195.003135 ↗
26. Mucins in cancer: protection and control of the cell surface10.1038/nrc1251 ↗
27. Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study10.1200/JCO.1991.9.7.1113 ↗
28. Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen
29. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine ehrlich tumor cells
30. Oriented immobilization of antibodies and its applications in immunoassays and immunosensors10.1039/an996210029r ↗
31. Conjugation of biomolecules with luminophore-doped silica nanoparticles for photostable biomarkers10.1021/ac010406+ ↗
32. Hermanson · 1996 · 418
33. Quantification and its applications in fluorescent microscopy imaging10.1111/j.1600-0854.2009.00938.x ↗